Type I Interferon Antagonists
Disclosed in certain embodiments is a method of preparing a Type 1 interferon antagonist comprising modifying a Type 1 interferon at the site of interaction with the interferon receptor subunit IFNAR-1 such that the binding affinity of the interferon to the IFNAR-1 subunit is reduced as compared to the native interferon, and corresponding compositions and methods of treatment thereof.
LANGER JEROME [US]; SCHREIBER GIDEON [IL]
Type of Offer:
« More Biotech Patents